Interactions Between the Serotonergic and Other Neurotransmitter Systems in the Basal Ganglia: Role in Parkinson’s Disease and Adverse Effects of L-DOPA
Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons in the substantia nigra. However, other non-dopaminergic neuronal systems such as the serotonergic system are also involved. Serotonergic dysfunction is associated with non-motor symptoms and complications, inc...
Main Authors: | Ana Muñoz, Andrea Lopez-Lopez, Carmen M. Labandeira, Jose L. Labandeira-Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-06-01
|
Series: | Frontiers in Neuroanatomy |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnana.2020.00026/full |
Similar Items
-
Broad Serotonergic Actions of Vortioxetine as a Promising Avenue for the Treatment of L-DOPA-Induced Dyskinesia
by: Carla Budrow, et al.
Published: (2023-03-01) -
Impairment of Serotonergic Transmission by the Antiparkinsonian Drug L-DOPA: Mechanisms and Clinical Implications
by: Cristina Miguelez, et al.
Published: (2017-09-01) -
Influence of intra-abomasal administration of L-DOPA on circulating catecholamines and feed intake in cattle
by: Eriton E. L. Valente, et al.
Published: (2023-02-01) -
Ropinirole Cotreatment Prevents Perivascular Glial Recruitment in a Rat Model of L-DOPA-Induced Dyskinesia
by: Osama F. Elabi, et al.
Published: (2023-07-01) -
Predictors of levo-dopa induced dyskinesias in Parkinson's disease
by: R T Athulya, et al.
Published: (2020-01-01)